Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...
Losing weight can feel like climbing a mountain with no clear path. The one-size-fits-all advice—like “eat less, move ...
No, it’s not ‘brat’, ‘demure’, or even ‘brain rot’; it’s Ozempic. The drug has become increasingly popular for helping people (including your favourite celebrities) lose weight ...
What started as pins and needles in the toes of an NZ jogger became total paralysis which left her "locked in" her own body. Pharmacist Anstey Campbell, 29, from Dargaville, noticed she had pins and ...
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...
Especially with a new family to think about. That medical appointment was in spring 2023, and the doctor explained that Ozempic, a drug for diabetic patients, was also being successfully used for ...
Nikki Glaser accurately called the 82nd Annual Golden Globe Awards "Ozempic's biggest night." (Sonja Flemming/CBS via Getty Images) ...
The Kansas City Chiefs headed west to take on the Denver Broncos on Sunday in the final game of the 2024 NFL regular season. The game held zero meaning for them after their Week 17 win over the ...
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With approximately 70% of American adults meeting the criteria for being obese or ...
Choi_ Nikolai - stock.adobe.com They’re not biting. As Ozempic and other GLP-1 drugs change the way America eats, food manufacturers are trying to whip themselves up a forkful of the action ...
That's the provocative question posed by Nina King, a 27-year-old Ph.D. student whose theory on the cultural impact of Ozempic—a weight-loss drug developed to treat type 2 diabetes—has gone ...